General Information |
| Clinical trials phase |
Phase 2 |
| Start date (estimated) |
2023-09-21 |
| End date (estimated) |
2025-12-31 |
| Clinical feature |
| Label |
interstitial lung disease |
| Link |
http://purl.obolibrary.org/obo/DOID_3082 |
| Description |
A lung disease that is characterized by inflammation and altered lung interstitium compromising pulmonary function and often has_symptom shortness of breath, dyspnea, and/or cough. |
|
Administrative Information |
| ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2400081256 |
| Other study identifiers |
| Name |
ChiCTR2400081256 |
| Description |
Chinese Clinical Trial Registry (ChiCTR) |
|
| Source weblink |
https://www.chictr.org.cn/showproj.html?proj=201722 |
| Sponsors |
China-Japan Friendship Hospital
|
Cells |
Recruitment |
| Recruitment Status |
Recruiting |
| Estimated number of participants |
45 |
